Dr. Andrew Yam

Biography

Andrew Yam is an early-career medical researcher associated with the Innate Tumour Immunology laboratory at the School of Biotechnology and Biomolecular Sciences at the University of New South Wales (UNSW) and the Immune Biotherapies Program at the Garvan Institute of Medical Research. A consultant clinical medical oncologist at the Kinghorn Cancer Centre, St Vincent’s Hospital in Sydney, he specializes in treating solid tumors and has played a significant role as a sub-investigator in multiple phase 1-3 clinical trials. Andrew completed his undergraduate studies at UNSW and acquired his postgraduate medical degree from the University of Sydney, achieving his Fellowship with the Royal Australasian College of Physicians (FRACP). His PhD research focused on microbial infections and their influence on the tumor microenvironment, particularly how they can convert chronic inflammation to acute responses, leading to the development of new bioparticle therapies tested in pre-clinical cancer models. Andrew's ongoing research aims to leverage anti-cancer microbial inflammation to combat cancers and prevent tumor recurrence, with a particular focus on enhancing the effectiveness of current immunotherapies and chemotherapies.

Research Interests

Experience

Awards